secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001664710-24-000086
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros CEO to present at Guggenheim Healthcare Innovation Conference on Nov 13
-----------------------------------------------------------------------------

- CEO Jasbir Seehra will speak at the Guggenheim Healthcare Innovation Conference on November 13, 2024 at 3:30 p.m. ET.
- A live webcast will be available at wsw.com/webcast/guggen/kros/1967811; replay for 90 days on ir.kerostx.com.
- No financial results or material business updates were disclosed in the press release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000086/0001664710-24-000086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000086/kros-20241106.htm
  HTML page:      https://secwatch.observer/filing/0001664710-24-000086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer